Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using in vitro models of hepatic metabolism

Rebecca Lawa Myriad Neuroscience, Mason, OH, USACorrespondence[email protected]

David Lewisa Myriad Neuroscience, Mason, OH, USA

Daniel Haina Myriad Neuroscience, Mason, OH, USA

Rachel Dauta Myriad Neuroscience, Mason, OH, USA

Melissa P. DelBellob Department of Psychiatry and Behavioral Neuroscience, College of Medicine, University of Cincinnati, Cincinnati, OH, USA

Jean A. Frazierc Eunice Kennedy Shriver Center, University of Massachusetts Chan Medical School, Worcester, MA, USA

Jeffrey H. Newcornd Icahn School of Medicine at Mount Sinai, New York, NY, USA

Erika Nurmie Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Los Angeles, CA, USA

Elizabeth S. Coganf Myriad Genetics, Salt Lake City, UT, USA

Susanne Wagnerf Myriad Genetics, Salt Lake City, UT, USA

Holly Johnsona Myriad Neuroscience, Mason, OH, USA

Jerry Lanchburyf Myriad Genetics, Salt Lake City, UT, USA

Your download is now in progress and you may close this window